TIMP-1 and CD82, a promising combined evaluation marker for PDAC.
Zhang J, Wu T, Zhan S, Qiao N, Zhang X, Zhu Y, Yang N, Sun Y, Zhang XA, Bleich D, Han X.
Zhang J, et al. Among authors: sun y.
Oncotarget. 2017 Jan 24;8(4):6496-6512. doi: 10.18632/oncotarget.14133.
Oncotarget. 2017.
PMID: 28030805
Free PMC article.